Group 4/14 Element Organic Compounds TRIZ Cases

Hydrolytic condensation combines mercapto and alkoxysilyl groups to reduce volatility while improving adhesion to glass and metals.

Silicon-containing cationic lipids address costly, inefficient nanoparticle preparation while supporting active-agent delivery.

Built-in fluorine avoids separate doping while the silicon compound produces low-dielectric films with chemical and thermal stability.

Controlled particle sizing helps microporous zirconium silicate exchange potassium in the gut while limiting urine-pH changes and inflammatory effects.

By combining carbamate, styryl, and sulfone functions, these compounds target cholinesterase activity, neuroinflammation, and oxidative stress in Parkinson’s disease.

Internal baffles and inert-gas flow separate ammonium chloride solids from silylamine products, reducing wall deposits and reactor downtime.

Modular synthesis of MCL1 inhibitors separates key functional regions for scalable manufacturing and adaptable bond-forming sequences.

A spiro-ring OLED host balances hole and electron transport to reduce concentration quenching and efficiency roll-off while extending device lifetime.

Pairing a polycyclic aromatic dopant with an anthracene host targets low efficiency and color purity while extending OLED lifetime.

A tailored silicon precursor reduces ALD growth per cycle, enabling very thin films and precise silicon content in semiconductor dielectrics.

Planar N-benzyl piperidines struggle to reach DCN1’s N-acetyl pocket; 3D pyrazolo-pyridones improve binding and oral bioavailability.

Fluorinated ether chemistry tunes the surface layer’s F content to retain fingerprint stain removability while improving protective film adhesion.

See how a melamine-based alkoxysilyl compound forms a hybrid coating that preserves metal–resin adhesion under accelerated stress.

Controlled addition with tris(pentafluorophenyl) borane, base treatment, and vacuum distillation yields high-purity ethers with minimal waste.

Redox-switchable carboranes selectively capture and release low-concentration lithium from seawater without membranes or strong acids.

Zinc, copper, or iron enables selective (meth)acryloxy exchange, while inhibitors limit self-polymerization and preserve purity.

A Siponimod synthesis removes column purification to raise yield and cut solvent use.

This case shows how a KRAS G12D degrader recruits E3 ligase to bypass direct covalent binding limits.

A two-step ketone and indenyl process uses direct precipitation to produce high-purity metallocenes with yields over 60%.

This case uses fused carbocyclic or heterocyclic rings in metal-coordinated ligands to raise EQE and refine infrared PHOLED emission.

Tin-based EUV photoresist reduces LER while preserving sensitivity and resolution.

This case uses cereblon-binding molecular glues to recruit CDK2, driving ubiquitination and proteasomal degradation for cancer therapy.

A composite emission layer uses a heterocyclic silicon dopant to balance blue-light luminance, energy use, and lifespan.

This synthesis case uses chiral auxiliary control to limit α-aldehyde epimerization while enabling novel cancer compounds.

A phosphine-phenol catalyst sustains olefin activity at higher temperatures.

A carbazole and dibenzocarbazole host combination supports efficient, stable OLED emission and longer device lifespan.

Asymmetric hafnium metallocenes raise rubber-phase viscosity while preserving melting point.

This case combines condensed cyclic emission materials with hole transport compounds to improve luminance and reduce driving voltage.

A host-guest emission layer uses a heterocyclic compound to improve blue-light luminance, energy efficiency, and lifespan.

This case combines an indole-functionalized bisphosphoramidite with rhodium to sustain linear-aldehyde selectivity during hydroformylation.

Green-absorbing organic compounds improve sensor sensitivity and thermal stability.

An organotin alkoxide-amide and water-vapor sequence forms smoother oxo films with 2–50 Å/cycle growth.

This case uses selective GPX4 inhibitors to exploit lipid peroxidation vulnerability in aggressive, drug-resistant cancer cells.

This case uses small molecules to stabilize mutant p53, restore DNA binding, and activate apoptosis, arrest, and senescence in cancer cells.

Metal-ligand complexes improve olefin selectivity and molecular weight control at high temperatures.

Simultaneous feeding with a polymerization inhibitor and platinum catalyst enables controlled synthesis and reduces runaway risk.

Silane groups form crosslinked siloxane networks, helping epoxy coatings resist weathering without immediate two-component mixing.

A low-power plasma process uses carbon-carbon triple-bond precursors to deposit void-free silicon carbide in substrate features.

Fluorinated polyether and cyclic silane chemistry forms a durable, water-repellent coating that resists repeated touch friction.

The case uses aliphatic hydrocarbons with attached disilylamine groups to form stable, reactive precursors for silicon-containing films.

Novel benzimidazole derivatives target DAAO inhibition to support NMDA receptor function.

Silazane-based deposition forms durable, high-purity barriers that limit moisture and oxygen permeation in flexible OLEDs.

Ring-structured compounds improve green-light sensitivity and thermal stability in image sensors.

This PSMA-targeted ligand-SIFA-chelator conjugate improves biodistribution while reducing hydrophobicity and kidney accumulation.

Small HOMO-LUMO overlap and ΔEST support efficient RISC, stable films, lower turn-on voltage, and longer OLED life.

A porous inorganic carrier limits pore closure during elongation, supporting purer, higher-yield synthesis of long-strand nucleic acids.

Bulky hydrophobic silicon groups lower melting points and viscosity, enabling fibre impregnation and lower-temperature curing.

This case uses benzotriazole compounds to block the Keap1–Nrf2 interface, improving activation specificity for oxidative-stress diseases.

This case uses hydrolyzable mesembrine prodrugs to replace variable extracts with stable, predictable pharmacokinetic delivery.

This organic EL case uses rigid spiro compounds to suppress Dexter energy transfer for pure blue light and longer device life.